Antimicrobials and antimicrobial resistance
Publication Date
December 12, 2017
Creator
Abstract
Drug discovery and development is becoming increasingly harder due to scientific bottlenecks, increased regulation from approval bodies and economic circumstance. Using unusual approaches to drug discovery can fast-track the production of new antimicrobials, as is the case with drug repurposing. There is a strong need for antimicrobial agents that bacteria can’t develop resistance to and the best way to address this is by developing drugs that do not create a strong selection for resistance. Antivirulence drugs are ideal in this respect as they do not target essential biological processes. It is naïve, however, to assume that bacteria will never develop resistance to any of the antibiotics they are presented with. Careful control over the use of antibiotics should be employed to prevent the development and spread of resistance if we are to avoid the upcoming antibiotic apocalypse.
Item Type
ethesis
Thesis Type
MRes
Supervisors
Subjects (LC)
Associated Schools / Departments
School of Life Sciences
eprints ID
48053
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
![Thumbnail Image]()
Name
Smith_Frances_MResThesis_FinalandRevised_Confidential.pdf
Type
Full-text
Description
Examined
Size
7.24 MB
Format
Adobe PDF
Checksum (MD5)
8e6b44f404f84cf8bef2e5b0b3b0e9a9
Name
Smith_Frances_MResThesis_FinalandRevised_ConfidentialRemoved.pdf
Type
Full-text
Description
Reader
Size
7.06 MB
Format
Adobe PDF
Checksum (MD5)
67fac05e934228bf0590234b8dde32fd